Answer
Headache is a common adverse reaction to daridorexant hydrochloride, meaning it occurs in at least 1 in 100 but fewer than 1 in 10 people.
Sources for this answer
- QUVIVIQ 50 mg film-coated tabletsIdorsia Pharmaceuticals UK Ltd · emc · SmPC §4.8 Undesirable effects · Version 5Document updated
Sources checked